Navigation Links
Novo Nordisk Inc. Announces Exclusive Agreement With Upsher-Smith Laboratories, Inc. to Market Vagifem® 10 mcg
Date:8/23/2010

PRINCETON, N.J., Aug. 23 /PRNewswire-FirstCall/ -- Novo Nordisk Inc. today announced that it has signed an exclusive agreement with Upsher-Smith Laboratories, Inc. to market Vagifem® (estradiol vaginal tablets) 10 mcg.  Under the terms of the agreement, Upsher-Smith will exclusively market Vagifem® 10 mcg to physicians in the U.S. beginning August 2 through the company's existing field sales force.

Novo Nordisk introduced Vagifem® 10 mcg to the U.S. market earlier this year.  The new dose replaces Vagifem® 25 mcg dose, which was discontinued on July 30, 2010.

"This partnership with Upsher-Smith supports the launch and conversion of the U.S. market to Vagifem® 10 mcg," said Eddie Williams, Vice President of Biopharmaceuticals at Novo Nordisk.  "Leveraging Upsher-Smith's experienced sales force, we are able to maintain our commitment to patient care and the medical community by making sure that physicians are aware of Vagifem® 10 mcg for treating menopausal women with symptoms of atrophic vaginitis."

"The alignment of our two organizations and our products, which offer low-dose estrogen treatments for menopausal women, make this a unique partnership opportunity," said Tom Burke, Executive Vice President, Commercial Operations at Upsher-Smith.  "The combined history of our two companies offers more than two centuries of experience bringing meaningful pharmaceutical products to the marketplace."

Financial terms of the agreement are not being disclosed.

Important Safety Information

What is the most important information I should know about Vagifem® (an estrogen hormone)?

  • Using estrogen-alone may increase your chance of getting cancer of the uterus (womb) Report any unusual vaginal bleeding right away while you are using Vagifem®. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb). You
    '/>"/>

SOURCE Novo Nordisk Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
2. Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes
3. Novo Nordisk Wins Design Award for NovoTwist(TM) Needle
4. Novo Nordisk is Changing Possibilities in Hemophilia
5. Novo Nordisks Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes
6. Novo Nordisk Awarded Department of Veterans Affairs National Insulin Contract
7. Novo Nordisk partners with international scientific community for Victoza(R) cardiovascular outcomes trial
8. Novo Nordisk Awards More Than $300,000 in Grants to Support Education and Community Health Programs
9. Novo Nordisk Announces Resources to Help Support Kids with Diabetes Attending Summer Camp
10. Novo Nordisk Addresses Innovation in Diabetes Care in Second Issue of Industry Resource for Information on Diabetes and Chronic Disease
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , June 25, 2015 Research and ... Diagnostics Market by Technology, Imaging and by Application - Forecast to ... diagnostics market is expected to reach $13.1 Billion in 2020 from ... 12.9%. The market is dominated by North ... Asia , and Rest of the World (RoW). The ...
(Date:7/2/2015)...  The Green Exchange, Inc., the developer,s of "Loud ... mobile app that connects cannabis growers directly to patients ... today that their service provides the fastest delivery on ... than half a dozen other delivery apps that have ... unique in that it connects growers directly with ...
(Date:7/2/2015)... Pharma Major Lupin Limited today announced ... Russia subject to certain closing conditions. ... which recorded RUB 765 billion in sales, placing it as ... in 2014 (IMS Health). For over a decade, Russian pharmaceutical ... this trend, projecting Russia to be ...
Breaking Medicine Technology:Global Cancer Diagnostics Market Report 2015 - Technology, Imaging and by Applications Forecasts to 2020 for the $13 Billion Industry 2New Cannabis Delivery App Gets Product to Patient in Under 7 Minutes 2Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3
(Date:7/4/2015)... NY (PRWEB) , ... July 04, 2015 , ... Chronic ... 15% of chronic pain sufferers have pain located in the neck. Another 19% suffer ... the neck. Chiropractic literature suggests that 45% of American workers must deal ...
(Date:7/3/2015)... ... July 03, 2015 , ... Brendon Burchard's new ... a buzz of media attention. In an effort to spread the news, a ... , "These days many people are feeling overwhelmed by stress and fatigue," reports ...
(Date:7/3/2015)... , ... July 03, 2015 , ... Renowned rhinoplasty ... dates for the 2016 Dallas Rhinoplasty Symposium . To be held from March ... meeting will be held at the Westin Galleria Dallas. , Designed to take participants ...
(Date:7/3/2015)... ... 03, 2015 , ... Smoothies are all the rage right now and all ... quality ingredients. Aurora Natural is proud to introduce a new line of all natural ... antioxidants, vitamins and minerals! , Aurora is offering a variety of blends and stand-alone ...
(Date:7/3/2015)... ... ... " Selfie on a Stick ” was featured on NewsWatch as part of its ... Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted the review and ... every smartphone has an incredibly powerful camera built into it. And when someone is ...
Breaking Medicine News(10 mins):Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:Learn How to Take Selfies like Kendall Jenner 2
... CITY, Dec. 5 /PRNewswire-FirstCall/ - DiagnoCure Inc. (TSX: CUR), ... and delivering laboratory services, announced today that the Company ... end results on December 17, 2008, at approximately 5:00 ... conference call, which will be held on December 18, ...
... by medical negligence moves into new suite on Washington Avenue ... ... Offices of Christian A. Lodowski , a boutique law firm that handles ... , ,The firm has moved into an elegant suite at 600 Washington ...
... easy-to-use resources to grow new business. , ... Columbus, ... it has launched Phase I of PHYZOOM, a suite of web-based ... marketing and communication products including detailed physician and practice profiles, easy ...
... fibrosis (IPF) are three times as likely to experience ... according to a recent study that analyzed the risk ... and more than 3,500 matched controls. , "If you ... roughly a three-fold increased risk of acute coronary syndrome, ...
... Care Without Harm and the World Health Organization today launched a ... affordable alternatives. , , The announcement ... to Mercury in Health Care, an event sponsored by the two ... , "This initiative aims to replace no less than ...
... Ore., Dec. 4 Joe,s Sports & Outdoor stores,across ... months of,August and September for the Children,s Cancer Association ... opportunity to showcase,their compassion and generosity by donating to ... CCA Founder and CEO, Regina ...
Cached Medicine News:Health News:DiagnoCure announces fourth quarter and full year 2008 earnings conference call and webcast 2Health News:Law Offices of Christian Lodowski, Medical Malpractice Attorney, Relocates to New Office Park in Towson 2Health News:OnKua, Launches Phase I Of "Phyzoom" A Web-Based Physician Marketing And Customer Relationship Management Product 2Health News:OnKua, Launches Phase I Of "Phyzoom" A Web-Based Physician Marketing And Customer Relationship Management Product 3Health News:Double threat: Deadly lung disease also linked to heart attacks 2Health News:Health Care Without Harm, WHO Announce Partnership for Global Reduction of Mercury-Based Medical Devices 2Health News:Joe's Sports & Outdoor In-Store Promotion Raises $18,000 for the Children's Cancer Association 2
... technology - Until now, if you wanted ... some of your patients while continuing to ... of patients, you had to keep a ... that has changed with Lifecard 12 - ...
This EIA microplate opens new perspectives in the direct detection of Chlamydia. The choice of microplate immunoenzymatic technology and the use of a monoclonal antibody result in a combination of c...
... Kit is a direct antigen detection system, that ... uses polyclonal and monoclonal antibodies to detect RSV ... the specificity and reproducibility of monoclonal antibodies with ... Qualitative results are availalbe within 90 minutes. The ...
... Every Bard BrachyStar® Needle is designed ... an efficient and clinically effective brachytherapy procedure. ... featuring ultra-sharp tips and polished surfaces for ... of needle configurations and sizes assures an ...
Medicine Products: